AMMI Canada is developing an accredited online HIV Script Concordance program with an anticipated launch date of Fall 2021.
The Learning Objectives are:
1. Understand the safety profile of each major NRTI (TAF, TDF, ABC) and the impact of boosted vs. unboosted therapy
2. Critically evaluate the appropriate NRTI regimens for specific patients and clinical contexts
3. Address the impact of genetic mutations and comorbidities on treatment decision